Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.43B |
| 2 |
Microsoft
MSFT
|
+$671M |
| 3 |
Spotify
SPOT
|
+$586M |
| 4 |
iShares Bitcoin Trust
IBIT
|
+$456M |
| 5 |
Eli Lilly
LLY
|
+$406M |
Top Sells
| 1 |
Apple
AAPL
|
+$2.7B |
| 2 |
Amazon
AMZN
|
+$1.48B |
| 3 |
Merck
MRK
|
+$884M |
| 4 |
Broadcom
AVGO
|
+$823M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$698M |
Sector Composition
| 1 | Technology | 15.81% |
| 2 | Healthcare | 13.31% |
| 3 | Financials | 13.08% |
| 4 | Industrials | 11.5% |
| 5 | Consumer Discretionary | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3251
Brink's
BCO
$4.83B
| $432K | ﹤0.01% |
3,733
-48,065
| -93% | -$5.56M |
|
|
IMA
3252
ImageneBio, Inc. Common Stock
IMA
$102M
| $431K | ﹤0.01% |
20,785
-8,774
| -30% | -$182K |
|
|
FBRT
3253
Franklin BSP Realty Trust
FBRT
$935M
| $431K | ﹤0.01% |
33,031
-178,725
| -84% | -$2.33M |
|
3254
Nuvectis Pharma
NVCT
$157M
| $431K | ﹤0.01% |
68,499
-50,960
| -43% | -$321K |
|
3255
Healthcare Services Group
HCSG
$1.16B
| $431K | ﹤0.01% |
38,556
-364,318
| -90% | -$4.07M |
|
3256
Annexon
ANNX
$266M
| $430K | ﹤0.01% |
72,655
-274,557
| -79% | -$1.63M |
|
3257
BlackRock MuniHoldings California Quality Fund
MUC
$1.02B
| $430K | ﹤0.01% |
+37,332
| New | +$430K |
|
3258
Waldencast
WALD
$223M
| $429K | ﹤0.01% |
117,769
+89,031
| +310% | +$324K |
|
3259
CAE Inc
CAE
$8.47B
| $428K | ﹤0.01% |
+22,818
| New | +$428K |
|
3260
Vanguard Russell 1000 Growth ETF
VONG
$31.9B
| $428K | ﹤0.01% |
4,432
-36,896
| -89% | -$3.56M |
|
3261
Aurinia Pharmaceuticals
AUPH
$1.68B
| $428K | ﹤0.01% |
58,325
+46,555
| +396% | +$341K |
|
|
PROF
3262
Profound Medical
PROF
$121M
| $427K | ﹤0.01% |
+53,633
| New | +$427K |
|
3263
Haymaker Acquisition Corp 4
HYAC
$328M
| $426K | ﹤0.01% |
40,000
| – | – |
|
3264
AN2 Therapeutics
ANTX
$35M
| $426K | ﹤0.01% |
397,925
-128,427
| -24% | -$137K |
|
3265
Unity Bancorp
UNTY
$521M
| $424K | ﹤0.01% |
12,462
-6,661
| -35% | -$227K |
|
3266
St. Joe Company
JOE
$3.01B
| $424K | ﹤0.01% |
7,275
-38,607
| -84% | -$2.25M |
|
3267
FS Bancorp
FSBW
$315M
| $423K | ﹤0.01% |
+9,518
| New | +$423K |
|
|
OPTN
3268
DELISTED
OptiNose
OPTN
| $422K | ﹤0.01% |
41,941
-29,768
| -42% | -$299K |
|
3269
China Yuchai International
CYD
$1.46B
| $421K | ﹤0.01% |
33,233
+22,299
| +204% | +$283K |
|
3270
Digimarc
DMRC
$204M
| $421K | ﹤0.01% |
+15,661
| New | +$421K |
|
3271
Franklin FTSE Japan ETF
FLJP
$2.38B
| $421K | ﹤0.01% |
+13,826
| New | +$421K |
|
|
ECC
3272
Eagle Point Credit Co
ECC
$887M
| $420K | ﹤0.01% |
+42,623
| New | +$420K |
|
3273
Vanguard Consumer Staples ETF
VDC
$7.61B
| $420K | ﹤0.01% |
1,922
-161
| -8% | -$35.2K |
|
3274
Byline Bancorp
BY
$1.33B
| $420K | ﹤0.01% |
15,680
-12,530
| -44% | -$335K |
|
|
SOL
3275
Emeren Group
SOL
$96.5M
| $419K | ﹤0.01% |
155,059
-127,628
| -45% | -$345K |
|